361 Capital »

G1 Therapeutics shares owned by 361 Capital

Quarter-by-quarter ownership of G1 Therapeutics (GTHX) shares owned by 361 Capital from 13F filings

Historical chart of 361 Capital investment in G1 Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including G1 Therapeutics held by 361 Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in G1 Therapeutics by 361 Capital

Quarter filed Position value Share count Share price at filing
2020-06-30 $1.1M 47k 24.26
2020-03-31 $603k 55k 11.03

More positions owned by 361 Capital

Schwab International Equity Et Intl Eqty Etf (SCHF)
Schwab U.s. Tips Etf Us Tips Etf (SCHP)
Schwab Emerging Markets Equity Emrg Mkteq Etf (SCHE)
Spdr Blmbg Barclays Inv Grd Fl Blomberg Brc Inv (FLRN)
Schwab U.s. Large-cap Etf Us Lrg Cap Etf (SCHX)
Schwab U.s. Reit Etf Us Reit Etf (SCHH)
Schwab U.s. Mid Cap Etf Us Mid-cap Etf (SCHM)
Cadence Design Systems (CDNS)
Deckers Outdoor Corporation (DECK)
Berry Plastics (BERY)
Howmet Aerospace (HWM)
Clorox Company (CLX)
Lear Corp Com Cl A (LEA)
AutoZone (AZO)
Dish Network Corp Cl A

View all positions for 361 Capital

Top funds holding G1 Therapeutics

Vanguard Group
Susquehanna International
Raymond James & Associates
D. E. Shaw & Co
Standard Life Aberdeen
Marshall Wace
Schonfeld Strategic Advisors
Jacobs Levy Equity Management
Bank of America Corporation
Jane Street
Connor, Clark & Lunn Investment Management
Level Four Advisory Services
Two Sigma Investments
Man Group
Citadel Advisors

View all funds holding G1 Therapeutics